CSIMarket
 
Neuphoria Therapeutics Inc   (NASDAQ: NEUP)
 

Neuphoria Therapeutics Inc's Customers Performance

NEUP



 
NEUP's Source of Revenues During the corresponding time, Neuphoria Therapeutics Inc While revenue at the Neuphoria Therapeutics Inc 's corporate clients

• List of NEUP Customers




for the same period Neuphoria Therapeutics Inc

• List of NEUP Customers





Neuphoria Therapeutics Inc's Comment on Sales, Marketing and Customers



The Company operates in the pharmaceutical and biotechnology sectors. It has a Research Collaboration and License Agreement with Merck, granting exclusive licensing of Bionomics Ltd. patent rights and know-how. The Company also maintains partnerships related to its legacy oncology programs, including an exclusive license of BNC101 to Carina Biotech for the development of CAR-T therapeutics. Its development focus includes early-stage small molecule discovery programs targeting central nervous system disorders and clinical-stage oncology programs aimed at cancer stem cells and tumor vasculature.





Neuphoria Therapeutics Inc’s Comment on Sales, Marketing and Customers


The Company operates in the pharmaceutical and biotechnology sectors. It has a Research Collaboration and License Agreement with Merck, granting exclusive licensing of Bionomics Ltd. patent rights and know-how. The Company also maintains partnerships related to its legacy oncology programs, including an exclusive license of BNC101 to Carina Biotech for the development of CAR-T therapeutics. Its development focus includes early-stage small molecule discovery programs targeting central nervous system disorders and clinical-stage oncology programs aimed at cancer stem cells and tumor vasculature.








NEUP's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Neuphoria Therapeutics Inc 15.25 0.00 -13.45 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Neuphoria Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Neuphoria Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Neuphoria Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.